Optometry Times

Practical chairside advice Posting Policy:
Thank you for liking the official Optometry Times page. We're glad you're here.
(13)

We are committed to creating a community that encourages self-expression and mirrors the values of Optometry Times including respect for the rights, dignity, and property of others. We ask all fans to do their part to help us achieve the goal. In doing that, we ask you not to post content that:
-is threatening, abusive, obscene, indecent, or objectionable.
-is deceptive, false, or misleading
-viol

ates the intellectual property rights of other people
-is illegal
-references a third party website or is self-promoting spam
-is inappropriate, offensive, or hateful
We reserve the right to remove any content or block users that violate our community guidelines, or that we determine are otherwise offensive to our community. All content must also comply with Facebook's policies as well. We would be sorry to see you go, but if you change your mind and no longer want to like our page, please feel free to "unlike" our page.

07/29/2024

Nicox SA announced the recruitment and randomization of the last patient in the US in its Denali Phase 3 trial of NCX 470.

The company noted that NCX 470 is a novel NO-donating bimatoprost eye drop currently in Phase 3 clinical development.

According to a news release, the Denali trial is evaluating NCX 470 safety and efficacy in patients with open-angle glaucoma or ocular hypertension and topline results continue to be expected in H2 2025, based on this completion of recruitment of patients in the U.S. and continuing good progress of the trial in China, where recruitment of patients is still ongoing. More than 95% of the total target number of patients have been randomized in this trial so far.

Read more: https://www.optometrytimes.com/view/nicox-announces-recruitment-of-last-us-patient-in-denali-phase-3-trial-of-ncx-470

07/28/2024

We are excited to invite you to EyeCon 2024 in Fort Lauderdale, FL! This premier event is tailored for ophthalmologists and optometrists eager to stay ahead in eye care. Join us for insightful presentations on the latest advancements, invaluable networking opportunities, and explore cutting-edge technologies and innovations in our exhibit hall.

🚨 Early Bird Pricing Ends This Thursday 🚨

Don't miss out on the savings—register now and secure your spot. We look forward to welcoming you to Fort Lauderdale and advancing the future of eye care together!

👉 Register today: https://ow.ly/grcC50SyMY5

07/28/2024

There's never a dull moment in optometry! Get the latest in business acquisitions and recent studies in this week's update: https://www.optometrytimes.com/view/what-happened-in-optometry-this-week-july-22---july-26

07/27/2024

Myopia has become a growing global health concern, with half of the world’s population to be impacted by the disease by 2050. In a recent study, researchers explored the association between myopia, anxiety, and mood disorders in Israeli adolescents ranging from 16 to 20 years old.

The participants were studied between 2011 and 2022, using evaluations to track sociodemographic and medical histories, physical examinations, and measurements of refraction and best-corrected visual acuity.

Read more:
https://www.optometrytimes.com/view/adolescents-with-myopia-have-a-higher-prevalence-of-anxiety-mood-disorders-study-finds

07/26/2024

"Making more sustainable choices in my practice and lifestyle is an ongoing process. My sister is an environmental scientist, so for years, I have kept a close eye on sustainability trends—not only in the news but also in the products I use in the eye care industry and in what I prescribe and recommend for my patients. My goal is to stay current on which companies value sustainability and shift to using their products as often as possible, both at work and at home.

"My commitment to living and working sustainably recently opened the door to a life-altering experience: a Plastic Bank immersion trip to Bali, Indonesia, sponsored by CooperVision. On the other side of the world, I saw and learned more about this partnership, its impact on the environment, and the difference it is making for the organization’s collectors and their families. The social enterprise is committed to helping humanity win the battle against plastic pollution and poverty. Its operations target countries in regions of the world where plastic pollution and poverty rates are at an all-time high, like Indonesia but also in the Philippines, Brazil, and Egypt," writes Joanna Reiman, OD.

Read more:
https://www.optometrytimes.com/view/how-contact-lens-prescription-brings-sustainability-into-focus

07/25/2024

A team of researchers at the National Institutes of Health (NIH), in a new analysis of data, have found that taking a daily supplement containing antioxidant vitamins and minerals can slow the progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision.

Read more:
https://www.optometrytimes.com/view/supplements-slow-disease-progression-during-late-stage-of-dry-amd-study-suggests

07/24/2024

Uveitis can be the first sign of a systemic autoimmune disease in children, according to Kefla G. Brown, OD, MS, director of pediatric optometric services at Ochsner Children’s Health Center in New Orleans, Louisiana. “The treatment is essentially the same, but it’s just sometimes the causes are not necessarily as obvious,” she said.

Read more:
https://www.optometrytimes.com/view/noa-2024-identifying-uncommon-etiologies-of-pediatric-uveitis

07/24/2024

"Historically, constraints such as limited parameter availability, lens rotation, and unreliable stabilization methods meant that some optometrists avoided prescribing soft toric contact lenses. The perception was that soft toric contact lenses took more chair time than they were worth and did not deliver visual outcomes that outperformed spherical options, especially for patients with low amounts of astigmatism. For some, a few bad experiences with toric lenses 10 or even 20 years ago may have left a negative impression that persists," writes Erin Rueff, OD, PhD, FAAO.

Read more:
https://www.optometrytimes.com/view/stability-is-an-important-quality-in-toric-lenses

07/23/2024

Bausch + Lomb Corp. announced an affiliate has acquired Trukera Medical, from its private equity owner, AccelMed Partners, and other shareholders.

According to the company, the tuck-in acquisition will help expand Bausch + Lomb’s surgical presence in the United States and contribute to its leading position in dry eye.

The company announced in the news release Trukera Medical, a US-based privately held ophthalmic medical diagnostic company, commercializes ScoutPro, a point-of-care portable device for precisely measuring osmolarity, or the salt content of a person’s tears.

Read more: https://www.optometrytimes.com/view/bausch-lomb-acquires-trukera-medical-ophthalmic-medical-diagnostic-company

07/23/2024

🎤Hear from Dr. Kelly Nichols on why optometrists should join her at EyeCon 2024! With her cutting-edge insights and extensive expertise, she'll be sharing invaluable knowledge that you won't want to miss.

Join us in Fort Lauderdale for a transformative experience in optometry. Early bird pricing ends August 1st—register now! https://ow.ly/Q7Fi50SHJyM

07/23/2024

Optometry Giving Sight (OGS) recently announced Lois Schoenbrun, FAAO, the executive director of OGS, will retire from the organization in December 2024. The announcement comes after Schoenbrun came out of retirement in 2022 to serve as interim executive director for OGS, according to a news release.

In a statement regarding her retirement, Schoenbrun said, “Although the initial interim period was intended to be short. I believed so passionately in the mission and quickly saw what a tremendous difference OGS makes in lives of people all over the world. So, the ‘interim’ appointment turned into nearly 2 and a half years. And I have enjoyed every minute of it.”

Read more:
https://www.optometrytimes.com/view/ogs-executive-director-lois-schoenbrun-announces-retirement

07/23/2024

Attendees of this year’s Ophthalmology Times and Optometry Times EyeCon 2024 meeting will find 2 key changes. Traditionally held later in the year along Florida’s west coast, the event now shifts to an earlier date and moves across the state to the southeast coast. The conference will take place at the Hilton Fort Lauderdale Marina on September 27 and 28, 2024.

Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, partner, physician, and surgeon at the Glaucoma Associates of Texas in Dallas serve as the Ophthalmology Times cochairs for the meeting.

Read more:
https://www.optometrytimes.com/view/eyecon-2024-oluwatosin-u-smith-md-talks-about-her-love-for-research-and-education

07/22/2024

Genentech, a member of the Roche group, announced 2-year data from the Phase III Pagoda and Pavilion studies evaluating Port Delivery System with ranibizumab (Susvimo) for the treatment of diabetic macular edema (DME) and diabetic retinopathy (DR), the 2 leading causes of vision loss in adults with diabetes.

Detailed results were presented at the American Society of Retina Specialists (ASRS) 2024 Annual Meeting in Stockholm, Sweden.

According to a news release, Susvimo is the first and only refillable eye implant that provides continuous delivery of a customized formulation of ranibizumab via the Port Delivery Platform.

Read more: https://www.optometrytimes.com/view/asrs-2024-new-data-for-susvimo-shows-sustained-efficacy-in-dme-dr

07/21/2024

Enjoy your weekend with your weekly optometric updates here:
https://www.optometrytimes.com/view/what-happened-in-optometry-this-week-july-15---july-19

07/20/2024

Cataract surgery has undergone transformational advancements in recent years, and one notable innovation is the adoption of dropless cataract surgery. This technique aims to eliminate the need for postoperative topical eye drops, streamlining the recovery process and potentially improving patient adherence. This article reviews the principles behind dropless cataract surgery, explores its advantages in the postoperative period, and discusses its implications for patient satisfaction and overall surgical outcomes.

Cataract surgery, a routinely performed procedure globally, has traditionally involved the use of postoperative topical eye drops to prevent infection and manage inflammation. Dropless cataract surgery represents a departure from this conventional approach by using intracameral drug delivery during surgery to provide extended postoperative prophylaxis.

Read more:
https://www.optometrytimes.com/view/dropless-cataract-surgery-revolutionizing-postoperative-care-for-enhanced-patient-outcomes

07/19/2024

This post is sponsored by OCULUS Inc.

Did you know thermal Radio Frequency (RF) expands patient eligibility and the time of year you can perform treatments? Intense Pulse Light (IPL) therapy is not recommended for certain skin types and sun exposure, unlike thermal RF.

The versatile DARWIN™ combines IPL and RF in one device, empowering you with the flexibility to treat patients of all skin types, all year long.

Like peanut butter and jelly, IPL & RF are better together. Unlock a new revenue stream and offer safe, efficient, and effective IPL & RF treatments.

Learn more at: https://oculususa.com/d/0ol4k83

07/19/2024

Cerebral visual impairment (CVI) encompasses an extensive range of visual impairments resulting from complications in the visual centers and pathways inside the brain, as opposed to dysfunctions in the eye itself. This impairment can occur due to a range of diseases, including neurological disorders such as cerebral palsy, head trauma, infections, and birth complications.

CVI includes several kinds of visual manifestations, including reduced visual acuity, restricted visual field, challenges in visual attention and identification, and limited visual processing. The severity and nature of visual symptoms can significantly differ across individuals and may not always be evident during routine eye examination.

Read more:
https://www.optometrytimes.com/view/keeping-patient-care-personalized

07/18/2024

For the National Optometric Student Association (NOSA), the National Optometric Association (NOA) Convention provided a busy week of events, lectures, and continuing education opportunities this year while preparing for future semesters of school. Every year, the convention also allows optometry students to build on invaluable relationships with practicing eye care providers to help them take as much knowledge as possible into the field they are entering, according to Babirekere Bakama, corresponding secretary for NOSA.

Read more: https://www.optometrytimes.com/view/noa-2024-nosa-reflects-on-noa-convention-s-networking-and-mentorship-opportunities-for-students

07/18/2024

For Eyerie Academics, ensuring that optometry students are prioritizing their wellbeing and entering both their medical field and exams feeling well prepared for what awaits them. Camille F. Cohen, OD, FAAO, and Janis James, OD, FAAO, cofounders of Eyerie, discuss lectures given during this year's National Optometric Association Convention and what lies ahead for the organization.

Watch the interview:
https://www.optometrytimes.com/view/noa-2024-eyerie-academics-takes-on-student-wellness-and-exam-preparation

07/17/2024

Artificial intelligence (AI) is finding its niche in medical research, with more and more applications being explored. A team of researchers in the United Kingdom (UK) are exploring AI to simplify appropriate patient recruitment in trials focused on geographic atrophy (GA) associated with age-related macular degeneration (AMD).

First authors and PhD candidates Dominic J. Williamson and Robbert R. Struyven point out that developing new treatments is expensive, can take decades, and relies heavily on data from clinical trials to demonstrate the safety and efficacy of the new treatments. “Today, challenges in recruiting participants stand as a significant obstacle in clinical trials.Time taken to fully recruit a trial adds significantly to the cost and can lead to delays, with up to 86% of trials not finishing on schedule,” the researchers write.

Read more:
https://www.optometrytimes.com/view/coupling-of-clinical-trial-recruitment-and-ai-eases-the-burden-of-ga-studies

07/17/2024

Sherrol A. Reynolds, OD, gives insight into her highlights from this year's National Optometric Association (NOA) Convention, which shone a spotlight on advocating for visual health for minority populations, in an exclusive interview with Optometry Times.

Watch the interview:
https://www.optometrytimes.com/view/noa-2024-past-president-speaks-on-organization-s-continued-initiatives

07/16/2024

Spanish investigators led by Barbara Burgos-Blasco, MD, PhD, reported a connection between alopecia areata and corneal abnormalities due to systemic inflammation. She is from the Ophthalmology Department, Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Madrid.

Some studies have reported ocular pathologies in patients with alopecia areata, which is defined as a common immune-mediated form of non-scarring hair loss of the scalp, that include mostly retinal and lenticular abnormalities; others have reported increased prevalence rates of cataract in patients with alopecia areata, likely because of corticosteroid therapy or the common embryonic origin of the skin and the lens from the ectoderm.

Read more: https://www.optometrytimes.com/view/potential-underlying-corneal-pathologies-associated-with-alopecia-areata

07/16/2024

OKYO Pharma has announced its plan to advance OK-101 into a phase 2 clinical trial of neuropathic corneal pain, expected to begin in Q3 of 2024.

The announcement of this trial follows the FDA clearance of the Investigational New Drug (IND) application of OK-101 for neuropathic corneal pain back in February.

OK-101 is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune cells of the eye responsible for the inflammatory response.

Read more:
https://www.optometrytimes.com/view/okyo-pharma-outlines-plans-for-phase-2-clinical-trial-of-ok-101-in-neuropathic-corneal-pain

07/15/2024

Whether seeing or non-seeing, prosthetic eye patients should be treated from the chair the same as patients without prosthetics, according to Philip Aitseboamo, OD, PhD. He outlines his talk, "Ocular Prosthetics for Seeing and Non-seeing Eye," which he presented at the National Optometric Association Convention this year, in an interview with Optometry Times.

Watch the interview: https://www.optometrytimes.com/view/noa-2024-the-dos-and-don-ts-of-prosthetic-eye-care

07/14/2024

Catch up on this week's developments from your favorite optometric publication here: https://www.optometrytimes.com/view/what-happened-in-optometry-this-week-july-8---july-12

07/13/2024

Boston researchers led by first author Jimena Tatiana Hathaway, MD, MPH, reported that there is a potential risk of the development of non-arteritic ischemic optic neuropathy (NAION) associated with prescriptions for semaglutide (Wegovy, Ozempic, Novo Nordisk). Prescriptions with semaglutide are FDA approved to treat obesity and type 2 diabetes, respectively.

Hathaway is from the Harvard T.H. Chan School of Public Health, and the Department of Ophthalmology, and Neuro-Ophthalmology Service Massachusetts Eye and Ear, Harvard Medical School, all in Boston.

Read more:
https://www.optometrytimes.com/view/study-finds-potential-link-between-semaglutide-and-risk-of-non-arteritic-ischemic-optic-neuropathy

07/12/2024

With myopia remaining one of the hottest topics in optometry, educating patients and optometric staff alike on treatment options and slowing progression. According to Ashley Wallace-Tucker, OD, FAAO, FSLS, ABO Dipl, looking to the future of treatment and management can inform what optometric staff can do in the present. “I recommend having the patient come back in six months, just for maybe your check in, and just assess what’s going on there and then have the conversation again,” she said. “Then at the year mark, have the conversation again.”

Read more:
https://www.optometrytimes.com/view/noa-2024-myopia-management-starts-with-education

07/12/2024

"Artificial intelligence (AI) is now everywhere—not just in our day-to-day lives but also in the rapidly evolving landscape of health care technology. It is making significant strides in creating efficiencies at home, in the car, in schools, and at our doctor appointments. In the health care space, with the promise of enhancing the efficiency of clinical documentation in our electronic health record (EHR) systems, it can have a significant positive impact not only on the quality of patient care but also on the satisfaction of its doctor users," writes Kiranjeet Sran, OD.

Read more:
https://www.optometrytimes.com/view/a-closer-look-at-ai-utilization-with-electronic-health-record-systems

07/11/2024

The American Board of Opticianry and National Contact Lens Examiners (ABO & NCLE) and the National Federation of Opticianry Schools (NFOS) have announced the formation of the United Opticians Association (UOA), a new international organization for spectacle and contact lens optician professionals. The organization also works to connect national organizations, including the Opticians Association of America (OAA), with the ABO & NCLE and NFOS, according to a news release.

Read more:
https://www.optometrytimes.com/view/abo-ncle-and-nfos-announce-formation-of-the-united-opticians-association

07/10/2024

"Professional practice guidelines can help to establish a level understanding for how a particular condition should be diagnosed and managed. Formal guidelines bridge the gap between different generations of optometrists, establishing evidence-based standards for all of us, whether we have been in practice for 2 years or 2 decades. And for primary eye care doctors like me, they can be a very helpful reminder. In any given day, I see patients ranging in age from 5 to 85 years, and I deal with conditions ranging from amblyopia to age-related macular degeneration. There are a lot of things on my radar, so I actively use guidelines from the American Optometric Association (AOA) to develop processes and protocols that keep my offices up to date, especially for conditions we might not see as often," writes Katie Gilbert Spear, OD, MPH.

Read more: https://www.optometrytimes.com/view/elevating-optometric-keratoconus-management

Address

24950 Country Club Boulevard, Ste 200
North Olmsted, OH
44070

Telephone

+14402438100

Website

https://www.optometrytimes.com/

Alerts

Be the first to know and let us send you an email when Optometry Times posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Optometry Times:

Videos

We are excited to invite you to EyeCon 2024 in Fort Lauderdale, FL! This premier event is tailored for ophthalmologists and optometrists eager to stay ahead in eye care. Join us for insightful presentations on the latest advancements, invaluable networking opportunities, and explore cutting-edge technologies and innovations in our exhibit hall. 🚨 Early Bird Pricing Ends This Thursday 🚨 Don't miss out on the savings—register now and secure your spot. We look forward to welcoming you to Fort Lauderdale and advancing the future of eye care together! 👉 Register today: https://ow.ly/grcC50SyMY5

🎤Hear from Dr. Kelly Nichols on why optometrists should join her at EyeCon 2024! With her cutting-edge insights and extensive expertise, she'll be sharing invaluable knowledge that you won't want to miss. Join us in Fort Lauderdale for a transformative experience in optometry. Early bird pricing ends August 1st—register now! https://ow.ly/Q7Fi50SHJyM

We are excited to invite you to EyeCon 2024 in Fort Lauderdale, FL! This premier event is tailored for ophthalmologists and optometrists eager to stay ahead in eye care. Join us for insightful presentations on the latest advancements, invaluable networking opportunities, and explore cutting-edge technologies and innovations in our exhibit hall. 🚨 Early Bird Pricing Ends August 1, 2024 🚨 Don't miss out on the savings—register now and secure your spot. We look forward to welcoming you to Fort Lauderdale and advancing the future of eye care together! 👉 Register today:https://ow.ly/7hOP50SrMzU

🚨 June Issue Alert! 🚨 The latest edition of Optometry Times is out now. Stay ahead with the latest research and insights in the field of optometry. Access the June 2024 issue here: https://bit.ly/3XA1CF9

Exclusive interview with EyeCon's event chair, Paul Chous, discussing what makes EyeCon a standout event in the optometry world! Don't miss out on our early bird prices – secure your spot before the prices go up! https://ow.ly/2zS950S4oqQ

🚨 May Issue Alert! 🚨 The latest edition of Optometry Times is out now. Stay ahead with the latest research and insights in the field of optometry. Don't miss out! Access the May 2024 issue here: https://bit.ly/3UNrdav

The Patient Whisperers reveal their secrets to growing a patient network beyond the chair by utilizing social media during their 2024 CIME keynote presentation. Learn more: https://www.optometrytimes.com/view/cime-2024-keynote-speakers-the-patient-whisperers-share-social-media-secrets-in-keynote-presentation

Sponsored by OCULUS Inc 📣To celebrate our joint 80th anniversary, we’re thrilled to unveil an exclusive offer you won’t want to miss! Get $5,000 lens bank credit with WAVE Contact Lens System®, EyePrint Prosthetics, or AVT when you buy any OCULUS Pentacam® or Keratograph® 5M now through May 31, 2024!* The Pentacam® models are best suited for fitting sclerals and ortho-k lenses, while the Keratograph® 5M is ideal for corneal GPs and ortho-ks. Achieve the best fits and streamline your workflow with OCULUS diagnostic solutions while earning $5,000 in lens bank credit with your favorite contact lens brands! Learn more and seize our limited-time offer before it’s too late at: https://bit.ly/joint-anniversary-offer *Terms and conditions apply; offer only valid in the US. #OCULUS #WAVE #EyeprintProsthetics #AVT #SpecialOffer #ContactLensFitting

🚨 April Issue Alert! 🚨 The latest edition of Optometry Times is out now. Stay ahead with the latest research and insights in the field of optometry. Don't miss out! Access the April 2024 issue here: https://bit.ly/3JgnqgK

🚨 March Issue Alert! 🚨 The latest edition of Optometry Times is out now. Stay ahead with the latest research and insights in the field of optometry. Don't miss out! Access the March 2024 issue here: https://ow.ly/a8oY50QVWys

🚨 Issue Alert! 🚨 🔍 Explore the latest in optometry with the newest issue of Optometry Times! Dive into insightful articles, expert opinions, and groundbreaking research. Don't miss out! Access the February 2024 issue now:https://ow.ly/r3y350QGHva

🚨 The January issue of Optometry Times is out now! 🚨

EyeCon 2023

EyeCon 2023 Watch Day 2 of EyeCon Live and earn CE/CME as experts discuss the latest advancements in eye care. Don't miss your opportunity to earn your required credits before the end of the year! Looking for an engaging and interactive experience? Tune in to our live stream on gotoper.com/EyeconOTV, where you can ask the esteemed faculty your burning questions in real time.

EyeCon 2023

EyeCon 2023 Join us now for a live CE/CME symposium and discover the cutting-edge advancements in eye care. Don't miss the opportunity to earn your required credits before the holidays at EyeCon! Looking for an engaging and interactive experience? Tune in to our live stream on gotoper.com/EyeconOTV, where you can ask the esteemed faculty your burning questions in real time.

At the Silverado Resort in Napa Valley, you can eat lunch on a patio overlooking mountains and golf courses and....you can earn COPE CE? That's right! Check out CRU Eye Symposium; it's a unique combination of education, vacation and relaxation! https://ow.ly/zMkq50PJRIP

Sponsored by American Academy of Optometry The American Academy of Optometry's annual meeting offers something for everyone, featuring exceptional continuing education, extensive networking opportunities, and exciting special events over the course of four days, along with opportunities to meet with our exhibitors and learn about the latest innovations in the optometric industry. Don't miss your chance to attend Academy 2023 New Orleans, October 11-14! Online registration ends on October 7. Visit www.aaopt.org/2023

Sponsored by American Academy of Optometry Join the American Academy of Optometry for Academy 2023 New Orleans, October 11-14, 2023. Hear from past attendees about why they love going to the Academy's annual meeting each year. Online registration ends on October 7 – register now at www.aaopt.org/2023

At #NOA2023 in Fort Lauderdale, Florida, Rhea Magee, OD, presented a pediatric patient case as part of the Resident Grand Rounds. Watch the full interview here: https://ow.ly/Zw4M50P70kl

At NOA 2023, Brianna Rhue, OD, FAAO, FSLS, caught up with Optometry Times to tell us more about the now and how of myopia management. Watch the full video here: https://ow.ly/uGzY50P6X0U